Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 511

1.

Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death.

Kulkarni PM, Robinson EJ, Sarin Pradhan J, Gartrell-Corrado RD, Rohr BR, Trager MH, Geskin LJ, Kluger HM, Wong PF, Acs B, Rizk EM, Yang C, Mondal M, Moore MR, Osman I, Phelps R, Horst BA, Chen ZS, Ferringer T, Rimm DL, Wang J, Saenger YM.

Clin Cancer Res. 2019 Oct 21. pii: clincanres.1495.2019. doi: 10.1158/1078-0432.CCR-19-1495. [Epub ahead of print]

PMID:
31636101
2.

Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma.

Rizk EM, Seffens AM, Trager MH, Moore MR, Geskin LJ, Gartrell-Corrado RD, Wong W, Saenger YM.

Am J Clin Dermatol. 2019 Oct 10. doi: 10.1007/s40257-019-00475-1. [Epub ahead of print]

PMID:
31602560
3.

Aspiration during anaesthesia in the first 4000 incidents reported to webAIRS.

Kluger MT, Culwick MD, Moore MR, Merry AF.

Anaesth Intensive Care. 2019 Aug 22:310057X19854456. doi: 10.1177/0310057X19854456. [Epub ahead of print] No abstract available.

PMID:
31438719
4.

Measurement of patient-reported outcomes after laparoscopic cholecystectomy: a systematic review.

Alexander HC, Nguyen CH, Moore MR, Bartlett AS, Hannam JA, Poole GH, Merry AF.

Surg Endosc. 2019 Jul;33(7):2061-2071. doi: 10.1007/s00464-019-06745-7. Epub 2019 Apr 1.

PMID:
30937619
5.

Mental Simulation of Facial Expressions: Mu Suppression to the Viewing of Dynamic Neutral Face Videos.

Karakale O, Moore MR, Kirk IJ.

Front Hum Neurosci. 2019 Feb 8;13:34. doi: 10.3389/fnhum.2019.00034. eCollection 2019.

6.

Haemodynamic profiles of etomidate vs propofol for induction of anaesthesia: a randomised controlled trial in patients undergoing cardiac surgery.

Hannam JA, Mitchell SJ, Cumin D, Frampton C, Merry AF, Moore MR, Kruger CJ.

Br J Anaesth. 2019 Feb;122(2):198-205. doi: 10.1016/j.bja.2018.09.027. Epub 2018 Nov 15.

PMID:
30686305
7.

New tribal placement and review of Parapucaya Prell and Pucaya Ohaus (Coleoptera, Scarabaeidae, Dynastinae).

Paucar-Cabrera A, Moore MR.

Zookeys. 2018 Dec 11;(805):127-158. doi: 10.3897/zookeys.805.28524. eCollection 2018.

8.

Remote biochemical verification of tobacco use: Reducing costs and improving methodological rigor with mailed oral cotinine swabs.

Moore MR, Mason MJ, Brown AR, Garcia CM, Seibers AD, Stephens CJ.

Addict Behav. 2018 Dec;87:151-154. doi: 10.1016/j.addbeh.2018.07.004. Epub 2018 Jul 6.

PMID:
30032041
9.

Annotated catalog and bibliography of the cyclocephaline scarab beetles (Coleoptera, Scarabaeidae, Dynastinae, Cyclocephalini).

Moore MR, Cave RD, Branham MA.

Zookeys. 2018 Mar 22;(745):101-378. doi: 10.3897/zookeys.745.23685. eCollection 2018.

10.

Synopsis of the cyclocephaline scarab beetles (Coleoptera, Scarabaeidae, Dynastinae).

Moore MR, Cave RD, Branham MA.

Zookeys. 2018 Mar 22;(745):1-99. doi: 10.3897/zookeys.745.23683. eCollection 2018. Review.

11.

Reporting of complications after laparoscopic cholecystectomy: a systematic review.

Alexander HC, Bartlett AS, Wells CI, Hannam JA, Moore MR, Poole GH, Merry AF.

HPB (Oxford). 2018 Sep;20(9):786-794. doi: 10.1016/j.hpb.2018.03.004. Epub 2018 Apr 9.

12.

Chronic exposure to low-level cadmium induced zinc-copper dysregulation.

Satarug S, Nishijo M, Ujjin P, Moore MR.

J Trace Elem Med Biol. 2018 Mar;46:32-38. doi: 10.1016/j.jtemb.2017.11.008. Epub 2017 Nov 16.

PMID:
29413108
13.

Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays.

Wunderink RG, Self WH, Anderson EJ, Balk R, Fakhran S, Courtney DM, Qi C, Williams DJ, Zhu Y, Whitney CG, Moore MR, Bramley A, Jain S, Edwards KM, Grijalva CG.

Clin Infect Dis. 2018 May 2;66(10):1504-1510. doi: 10.1093/cid/cix1066. Erratum in: Clin Infect Dis. 2018 Sep 28;67(8):1313. Abstract corrected.

15.

Evaluation of an integrated multisector campaign to increase child helmet use in Vietnam.

Nhan LDT, Parker L, Son MTH, Parker EM, Moore MR, Sidik M, Draisin N.

Inj Prev. 2019 Jun;25(3):206-210. doi: 10.1136/injuryprev-2017-042517. Epub 2017 Nov 25.

PMID:
29175833
16.

Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA.

Link-Gelles R, Westreich D, Aiello AE, Shang N, Weber DJ, Rosen JB, Motala T, Mascola L, Eason J, Scherzinger K, Holtzman C, Reingold AL, Barnes M, Petit S, Farley MM, Harrison LH, Zansky S, Thomas A, Schaffner W, McGee L, Whitney CG, Moore MR.

BMJ Open. 2017 Aug 28;7(8):e017715. doi: 10.1136/bmjopen-2017-017715.

17.

Synopsis of the pelidnotine scarabs (Coleoptera, Scarabaeidae, Rutelinae, Rutelini) and annotated catalog of the species and subspecies.

Moore MR, Jameson ML, Garner BH, Audibert C, Smith ABT, Seidel M.

Zookeys. 2017 Apr 6;(666):1-349. doi: 10.3897/zookeys.666.9191. eCollection 2017.

18.

Opposed to the being of Henrietta: bioslavery, pop culture and the third life of HeLa cells.

Moore MR.

Med Humanit. 2017 Mar;43(1):55-61. doi: 10.1136/medhum-2016-011072. Epub 2016 Nov 15.

PMID:
28228572
19.

Pneumococcal Serotype 5 Colonization Prevalence Among Newly Arrived Unaccompanied Children 1 Year After an Outbreak-Texas, 2015.

Kobayashi M, Misegades L, Fleming-Dutra KE, Ahmed S, Gierke R, Nanduri S, Healy JM, Nguyen DT, da Gloria Carvalho M, Pimenta F, Waterman SH, Moore MR, Kim C, Whitney CG.

Pediatr Infect Dis J. 2017 Feb;36(2):236-238. doi: 10.1097/INF.0000000000001398.

20.

Mu rhythm suppression is associated with the classification of emotion in faces.

Moore MR, Franz EA.

Cogn Affect Behav Neurosci. 2017 Feb;17(1):224-234. doi: 10.3758/s13415-016-0476-6.

PMID:
27815729
21.

Cutaneous metastases from adenocarcinoma of the ovary.

McDonald HH, Moore MR, Meffert JJ.

JAAD Case Rep. 2016 Oct 12;2(5):406-407. eCollection 2016 Sep. No abstract available.

22.

Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study.

Link-Gelles R, Westreich D, Aiello AE, Shang N, Weber DJ, Holtzman C, Scherzinger K, Reingold A, Schaffner W, Harrison LH, Rosen JB, Petit S, Farley M, Thomas A, Eason J, Wigen C, Barnes M, Thomas O, Zansky S, Beall B, Whitney CG, Moore MR.

SSM Popul Health. 2016 Dec;2:587-594.

23.

Preparation of Underrepresented Males for Scientific Careers: A Study of the Dr. John H. Hopps Jr. Defense Research Scholars Program at Morehouse College.

Thompson RC, Monroe-White T, Xavier J, Howell C, Moore MR, Haynes JK.

CBE Life Sci Educ. Fall 2016;15(3). pii: ar40. doi: 10.1187/cbe.15-12-0263.

24.

Vital Signs: Deficiencies in Environmental Control Identified in Outbreaks of Legionnaires' Disease - North America, 2000-2014.

Garrison LE, Kunz JM, Cooley LA, Moore MR, Lucas C, Schrag S, Sarisky J, Whitney CG.

MMWR Morb Mortal Wkly Rep. 2016 Jun 10;65(22):576-84. doi: 10.15585/mmwr.mm6522e1.

25.

Stigma and Family Relationships of Middle-Aged Gay Men in Recovery.

Del Pino HE, Moore MR, Dacus JD, McCuller WJ, Fernandez L, Moore AA.

J Gay Lesbian Soc Serv. 2016;28(1):1-19. Epub 2016 Jan 29.

26.

Multistate Outbreak of Respiratory Infections Among Unaccompanied Children, June 2014-July 2014.

Tomczyk S, Arriola CS, Beall B, Benitez A, Benoit SR, Berman L, Bresee J, da Gloria Carvalho M, Cohn A, Cross K, Diaz MH, Francois Watkins LK, Gierke R, Hagan JE, Harris AM, Jain S, Kim L, Kobayashi M, Lindstrom S, McGee L, McMorrow M, Metcalf BL, Moore MR, Moura I, Nix WA, Nyangoma E, Oberste MS, Olsen SJ, Pimenta F, Socias C, Thurman K, Waller J, Waterman SH, Westercamp M, Wharton M, Whitney CG, Winchell JM, Wolff B, Kim C.

Clin Infect Dis. 2016 Jul 1;63(1):48-56. doi: 10.1093/cid/ciw147. Epub 2016 Mar 21.

PMID:
27001799
27.

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.

Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Holtzman C, Harrison LH, Zansky SM, Rosen JB, Reingold A, Scherzinger K, Thomas A, Guevara RE, Motala T, Eason J, Barnes M, Petit S, Farley MM, McGee L, Jorgensen JH, Whitney CG.

Lancet Respir Med. 2016 May;4(5):399-406. doi: 10.1016/S2213-2600(16)00052-7. Epub 2016 Mar 14.

PMID:
26987984
28.

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia.

Grijalva CG, Wunderink RG, Zhu Y, Williams DJ, Balk R, Fakhran S, Courtney DM, Anderson EJ, Qi C, Trabue C, Pavia AT, Moore MR, Jain S, Edwards KM, Self WH.

Open Forum Infect Dis. 2015 Sep 19;2(4):ofv135. doi: 10.1093/ofid/ofv135. eCollection 2015 Dec.

29.

Incidence of Pneumococcal Pneumonia Among Adults in Rural Thailand, 2006-2011: Implications for Pneumococcal Vaccine Considerations.

Piralam B, Tomczyk SM, Rhodes JC, Thamthitiwat S, Gregory CJ, Olsen SJ, Praphasiri P, Sawatwong P, Naorat S, Chantra S, Areerat P, Hurst CP, Moore MR, Muangchana C, Baggett HC.

Am J Trop Med Hyg. 2015 Dec;93(6):1140-1147. doi: 10.4269/ajtmh.15-0429. Epub 2015 Oct 26.

30.

Older Ethnic Minority Women's Perceptions of Stroke Prevention and Walking.

Kwon I, Bharmal N, Choi S, Araiza D, Moore MR, Trejo L, Sarkisian CA.

Womens Health Issues. 2016 Jan-Feb;26(1):80-6. doi: 10.1016/j.whi.2015.08.003. Epub 2015 Sep 26.

31.

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, Pilishvili T.

MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7. doi: 10.15585/mmwr.mm6434a4. Erratum in: MMWR Morb Mortal Wkly Rep. 2015 Oct 30;64(42):1204.

32.

Twenty Years of Active Bacterial Core Surveillance.

Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C.

Emerg Infect Dis. 2015 Sep;21(9):1520-8. doi: 10.3201/eid2109.141333.

33.

Emerging Infections Program Efforts to Address Health Equity.

Hadler JL, Vugia DJ, Bennett NM, Moore MR.

Emerg Infect Dis. 2015 Sep;21(9):1589-94. doi: 10.3201/eid2109.150275.

34.

Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections Program.

Moore MR, Whitney CG.

Emerg Infect Dis. 2015 Sep;21(9):1551-6. doi: 10.3201/eid2109.150395.

35.

Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.

Desai AP, Sharma D, Crispell EK, Baughman W, Thomas S, Tunali A, Sherwood L, Zmitrovich A, Jerris R, Satola SW, Beall B, Moore MR, Jain S, Farley MM.

Pediatr Infect Dis J. 2015 Nov;34(11):1168-74. doi: 10.1097/INF.0000000000000849.

PMID:
26226445
36.

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, Miller L, Scherzinger K, Thomas A, Farley MM, Zell ER, Taylor TH Jr, Pondo T, Rodgers L, McGee L, Beall B, Jorgensen JH, Whitney CG.

Lancet Infect Dis. 2015 Mar;15(3):301-9. doi: 10.1016/S1473-3099(14)71081-3. Epub 2015 Feb 3.

37.

Medication adherence skills training for African-American breast cancer survivors: the effects on health literacy, medication adherence, and self-efficacy.

Rust CF, Davis C, Moore MR.

Soc Work Health Care. 2015;54(1):33-46. doi: 10.1080/00981389.2014.964447.

PMID:
25588095
38.

Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012.

Griffin MR, Mitchel E, Moore MR, Whitney CG, Grijalva CG; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 7;63(44):995-8.

39.

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5.

40.

Negotiating Emotional Support: Sober Gay Latinos and their Families.

Del Pino HE, Moore MR, McCuller WJ, Zaldívar R, Moore AA.

J Gay Lesbian Soc Serv. 2014 Apr 1;26(2):222-243.

41.

Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers.

Harris AM, Beekmann SE, Polgreen PM, Moore MR.

Diagn Microbiol Infect Dis. 2014 Aug;79(4):454-7. doi: 10.1016/j.diagmicrobio.2014.05.008. Epub 2014 May 17.

42.

Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis.

Reynolds CA, Finkelstein JA, Ray GT, Moore MR, Huang SS.

Antimicrob Resist Infect Control. 2014 May 21;3:16. doi: 10.1186/2047-2994-3-16. eCollection 2014.

43.

Floral associations of cyclocephaline scarab beetles.

Moore MR, Jameson ML.

J Insect Sci. 2013;13:100. doi: 10.1673/031.013.10001.

44.

Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009.

Wortham JM, Zell ER, Pondo T, Harrison LH, Schaffner W, Lynfield R, Thomas A, Reingold A, Bennett NM, Petit S, Aragon D, Bareta J, Juni BA, Farley MM, Beall B, Moore MR.

Clin Infect Dis. 2014 May;58(9):1250-7. doi: 10.1093/cid/ciu108. Epub 2014 Feb 27.

PMID:
24585565
45.

Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.

Cho BH, Stoecker C, Link-Gelles R, Moore MR.

Vaccine. 2013 Dec 5;31(50):6011-21. doi: 10.1016/j.vaccine.2013.10.024. Epub 2013 Oct 19.

PMID:
24148572
46.

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group.

PLoS Med. 2013;10(9):e1001517. doi: 10.1371/journal.pmed.1001517. Epub 2013 Sep 24.

47.

Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.

Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, Harrison L, Farley MM, Aragon D, Nicols M, Kirley PD, Zansky S, Jorgensen J, Juni BA, Jackson D, Moore MR, Lipsitch M.

J Infect Dis. 2013 Oct 15;208(8):1266-73. doi: 10.1093/infdis/jit315. Epub 2013 Jul 12.

48.

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.

Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG.

N Engl J Med. 2013 Jul 11;369(2):155-63. doi: 10.1056/NEJMoa1209165.

49.

Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccine.

Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR.

Pediatrics. 2013 Aug;132(2):e324-32. doi: 10.1542/peds.2012-3350. Epub 2013 Jul 1.

PMID:
23821695
50.

Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020.

Link-Gelles R, Taylor T, Moore MR; Active Bacterial Core Surveillance Team.

Vaccine. 2013 May 24;31(22):2572-7. doi: 10.1016/j.vaccine.2013.03.049. Epub 2013 Apr 11.

PMID:
23583813

Supplemental Content

Loading ...
Support Center